Intervene Immune
PrivateLast Round
Seed
Dec 27, 2019
Total Funding Raised
$471,000
Company Overview
Intervene Immune is a biotechnology company that develops immuno-therapies and diagnostics designed for thymus regeneration and age-related immune system decline.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2C
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Intervene Immune Comps
Public and private peers based on sector, stage, and business model.
Intervene Immune Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Dec 27, 2019 |
Intervene Immune Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Longevitytech.fund | Seed |
| quadraScope Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 27, 2019
$471K raised from Longevitytech.fund and quadraScope Ventures.
Intervene Immune Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Intervene Immune's valuation, stock price, and market status.
